Related Experiment Videos

Pediatric septic shock: why has mortality decreased?-the utility of goal-directed therapy

Luisa E Arnal1, Fernando Stein

  • 1Department of Pediatrics, Baylor College of Medicine Residency Program and the Section of Pediatric Critical Care, Baylor College of Medicine and Texas Children's Hospital, Houston, TX 77030, USA.

Seminars in Pediatric Infectious Diseases
|July 26, 2003
PubMed

Insights

Childhood septic shock mortality has dropped 92% due to advances in goal-directed therapy and intensive care. Understanding innate immunity provides a basis for these treatments, though direct inflammatory cascade manipulation remains unproven.

Area of Science:

  • Pediatric critical care medicine
  • Immunology
  • Infectious diseases

Background:

  • Septic shock poses a significant threat to children.
  • Mortality rates for pediatric septic shock have seen a dramatic decline over recent decades.
  • Advances in intensive care and supportive measures have been crucial.

Purpose of the Study:

  • To analyze the factors contributing to the significant reduction in childhood septic shock mortality.
  • To explore the role of evolving scientific understanding in guiding clinical practice.
  • To evaluate the current status of therapies targeting the inflammatory cascade in septic shock.

Main Methods:

  • Review of historical mortality data for pediatric septic shock over 36 years.
  • Analysis of the impact of goal-directed therapy and intensive care unit (ICU) support.
  • Examination of research advancements in innate immunity and biomolecular processes.
  • Assessment of the clinical trial outcomes for anti-inflammatory therapies.

Main Results:

  • A 92% decrease in mortality from septic shock in children over the past 36 years.
  • Goal-directed therapy, intensive care, and supportive measures are key contributors to this improvement.
  • Enhanced understanding of innate immunity has informed the development of effective goal-directed therapies.
  • Therapies specifically targeting the inflammatory cascade have not yet demonstrated consistent safety and efficacy.

Conclusions:

  • Significant progress has been made in reducing pediatric septic shock mortality.
  • Continued research into innate immunity and biomolecular pathways is vital for further therapeutic development.
  • Caution is advised regarding therapies that directly manipulate the inflammatory cascade, pending further evidence.

Related Concept Videos

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...